Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
China Regenerative Medicine International Limited (HKG:8158)
Hong Kong
· Delayed Price · Currency is HKD
Full Chart
Watchlist
Compare
0.3850
-0.0150 (-3.75%)
Jun 1, 2026, 3:12 PM HKT
Overview
Financials
Statistics
History
Profile
Chart
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Semi-Annual
TTM
HKG:8158 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Mil
Millions
Data
Data Source
HKD
HKD
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Revenue
72.06
90.62
69.49
41.54
282.9
Revenue Growth (YoY)
-20.48%
30.41%
67.29%
-85.32%
55.32%
Cost of Revenue
30.14
32.96
50.06
3.91
215.17
Gross Profit
41.92
57.65
19.42
37.62
67.73
Selling, General & Admin
42.36
51.52
45.54
25.82
47.45
Operating Expenses
42.36
51.52
45.54
25.82
6.09
Operating Income
-0.44
6.14
-26.11
11.81
61.63
Interest Expense
-1.2
-1.13
-0.98
-0.78
-0.74
Interest & Investment Income
17.96
17.58
0.01
0
0.01
Other Non Operating Income (Expenses)
-1.13
-4.83
-80.66
-3.67
-1.67
EBT Excluding Unusual Items
15.19
17.75
-107.74
7.35
59.24
Other Unusual Items
-
-
0.04
0.91
5.05
Pretax Income
15.19
17.75
-107.7
8.27
64.29
Income Tax Expense
-12.34
-
-
3.71
12.47
Earnings From Continuing Operations
27.53
17.75
-107.7
4.56
51.83
Net Income to Company
27.53
17.75
-107.7
4.56
51.83
Net Income
27.53
17.75
-107.7
4.56
51.83
Net Income to Common
27.53
17.75
-107.7
4.56
51.83
Net Income Growth
55.05%
-
-
-91.21%
-
Shares Outstanding (Basic)
304
304
286
285
285
Shares Outstanding (Diluted)
304
304
286
285
285
Shares Change (YoY)
-
6.23%
0.34%
-
77.64%
EPS (Basic)
0.09
0.06
-0.38
0.02
0.18
EPS (Diluted)
0.09
0.06
-0.38
0.02
0.18
EPS Growth
55.17%
-
-
-91.21%
-
Free Cash Flow
4.02
17.68
10.52
-15.03
-3.83
Free Cash Flow Per Share
0.01
0.06
0.04
-0.05
-0.01
Gross Margin
58.17%
63.62%
27.95%
90.58%
23.94%
Operating Margin
-0.61%
6.77%
-37.58%
28.42%
21.79%
Profit Margin
38.20%
19.59%
-154.99%
10.97%
18.32%
Free Cash Flow Margin
5.59%
19.51%
15.13%
-36.17%
-1.35%
EBITDA
0.22
6.8
-25.54
11.98
61.71
EBITDA Margin
0.31%
7.50%
-36.75%
28.83%
21.81%
D&A For EBITDA
0.66
0.66
0.57
0.17
0.08
EBIT
-0.44
6.14
-26.11
11.81
61.63
EBIT Margin
-0.61%
6.77%
-37.58%
28.42%
21.79%
Effective Tax Rate
-
-
-
44.90%
19.39%